Jazz Pharmaceuticals Remains A Buy At Deutsche Bank Post Q2 Report
August 11, 2016 at 15:04 PM EDT
Deutsche Bank maintained its Buy rating on Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ: JAZZ) despite the company's second ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.